Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

Methods and G proteins for screening and identifying ligands of G protein-coupled receptors

BIOMARKERS OF CANCER

Combination therapy for the treatment of cancer using an anti-C-met antibody

Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells

Integrated compound discovery systems and methods

Methods of identifying, isolating and using odorant and aroma receptors

Human skin sample methods and models for validating hypotheses for mechanisms driving skin pigmentation

Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer

INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION

DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS

Novel Antitumor Agent and Method For Screening Same

Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells

ASSAY FOR SCREENING COMPOUNDS THAT SELECTIVELY DECREASE THE NUMBER OF CANCER STEM CELLS

Transcription biomarkers of biological responses and methods of use

Recurrent gene fusions in prostate cancer

Metabolic gene mesenchymal signatures and uses thereof

NOL3 is a predictor of patient outcome

Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt

Pluripotent cell lines and methods of use thereof

Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder

PACLITAXEL RESPONSE MARKERS FOR CANCER

NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF

Method of treating and reducing the risk of acute myelogenous leukemia

COMPOSITIONS AND METHODS FOR REGULATING CANCER-RELATED SIGNALING PATHWAYS

SCREENING METHODS FOR COGNITIVE ENHANCERS

Transgenic mice expressing microRNA34 that have cells displaying increased senescence and apoptosis

Methods for treatment of bacterial infections

Methods of inhibiting Alu RNA and therapeutic uses thereof

PHYSIOLOGICAL LIGANDS FOR GPR139

MAO-B INHIBITORS DERIVED FROM THE ONE-CARBON CYCLE

COMPOSITIONS AND METHODS FOR SCREENING AND TREATMENT OF STURGE-WEBER SYNDROME, KLIPPEL-TRENAUNAY-WEBER SYNDROME, AND PORT-WINE STAINS (PWSS)

METHOD FOR PREPARING IMPROVED CARDIOMYCOCYTE-LIKE CELLS

HUMAN SKIN SAMPLE METHODS AND MODELS FOR VALIDATING HYPOTHESES FOR MECHANISMS DRIVING SKIN PIGMENTATION

Compositions and methods for modulating an immune response

Transgenic comprising a human protein with a tendency to aggregate fused to a fluorescent protein

Transcriptomic biomarkers for individual risk assessment in new onset heart failure

MARKERS FOR MATURE BETA-CELLS AND METHODS OF USING THE SAME

Methods of novel therapeutic candidate identification through gene expression analysis in vascular related diseases

Methods of using ZSCAN4 for rejuvenating human cells

Signatures and determinants associated with prostate cancer progression and methods of use thereof

Gene and mutations thereof associated with seizure and movement disorders

Carbonic anhydrase IX-related markers and use thereof

Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particles

Renal cell carcinoma biomarkers

Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIP

COMPOSITIONS AND METHODS FOR TREATING BRAIN CANCER

Glatiramer acetate response biomarker mRNA potency assay

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of ovarian cancer using a real-time PCR platform

miRNA-based universal screening test (UST)

Markers of acute myeloid leukemia stem cells

KIF5B-RET fusion molecules and uses thereof

SUMOYLATION OF SERCA2a AND CARDIOVASCULAR DISEASE

Methods for lowering blood glucose

COMPOSITIONS AND METHODS FOR INFLUENCING SATIETY, LIPID METABOLISM, AND FAT UTILIZATION

Gene signature for predicting prognosis of patients with solid tumors

Modulation of growth hormone receptor expression and insulin-like growth factor expression

RNAi-based method of screening and characterizing drug combinations

Therapeutic agent for emphysema and COPD

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling

Mutant sodium channel Nav1.7 and methods related thereto

Screening methods for identifying specific inhibitors

Methods for detecting a genetic variation in subjects with parkinsonism

Circulating biomarkers for metastatic prostate cancer

Biomarkers of osteoarthritis

Method of treatment or prophylaxis of inflammatory pain

BCR-ABL1 splice variants and uses thereof

RNAi-based method of drug screening and characterization

Method for screening substances having weight-regulating action

Compositions and methods for the identification of inhibitors of retroviral infection

Methods and agents for modulating protocadherin-18 activity

Aging marker, method for evaluating aging inhibitor, and cancer inhibitor

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

Treatment of chronic pelvic pain syndrome

Administration of FGF9 for treatment of anxiety

gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis

Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides

Metastasis specific splice variants of Mena and uses thereof in diagnosis, prognosis and treatment of tumors

Modulators of alpha-synuclein toxicity

Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

Molecular marker for cancer stem cell

Markers associated with human double minute 2 inhibitors

Methods of diagnosing endometriosis

MicroRNAs and uses thereof

PCA3 genes

EGFR mutations

Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

Detecting and treating dementia

Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling

Metabolic diseases-related odorant receptor genes and use thereof

Methods and models for assessing anti-aging benefits of agents

Signatures and determinants associated with cancer and methods of use thereof

Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Genetic amplification of IQGAP1 in cancer

Methods of making antibodies that bind polypeptides involved in the process of bone remodeling

Methods for treating chronic pelvic pain syndrome

Use and identification of biomarkers for gastrointestinal diseases

Marker for determination of sensitivity to triplet combination anti-cancer agent

Method for treating synovial sarcoma

Pulmonary disease treatment and diagnosis based on Arhgef1

Biomarkers for theranostics

15-PGDH in colon cancer

Breast cancer susceptibility gene GT198 and uses thereof

Ultraconserved regions encoding ncRNAs

Methods and kits to predict therapeutic outcome of BTK inhibitors

Method of treating skin with microRNA modulators

Compounds that modulate oxidative stress

Cancer-associated antigen

Skin and hair color-controlling factor

Methods for monitoring methotrexate therapy

Method for screening for a therapeutic agent for idiopathic interstitial pneumonia

Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use

Method for predicting and preventing cardiovascular disease

Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease

Inhibition of tat activating regulatory DNA-binding protein 43

Micro-RNAs modulating immunity and inflammation

Genetic polymorphisms associated with psoriasis, methdos of detection and uses thereof

Markers of the male urogenital tract

Identification, assessment, and therapy of cancers with innate or acquired resistance to ALK inhibitors

Alternative splicing variant of OATP1B3 mRNA

Method of inhibiting Alu RNA and therapeutic uses thereof

TREATMENT OF HEPATOCYTE GROWTH FACTOR (HGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF

Methods and compositions for cell-proliferation-related disorders

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

Compositions and methods for detecting, diagnosing, and treating cancer

miRNAs involved in the blood brain barrier function

Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia

Tyrosine kinome

Phosphatidylinositol phosphate kinase type 1 gamma splice variants as biomarkers and drug targets for epithelial cancers

METHOD FOR DETECTION OF PREDISPOSITION TO ATHEROSCLEROSIS, CORONARY HEART DISEASE AND RELATED CONDITIONS

Methods and compositions for detecting gastrointestinal and other cancers

Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter

Detection and treatment of LRP4-associated neurotransmission disorders

PLASMA MICRORNAS FOR THE DETECTION OF EARLY COLORECTAL CANCER

MATERIALS AND METHODS TO DETECT PYRIMIDINE-PYRIMIDINE DIMER FORMATION

Method and a Kit to Predict Response to Antidepressant Treatment

Method of diagnosing and treating cancer

Transplant Rejection Markers

Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer

Method of treating colorectal cancer tumor

Prognostic molecular signature of sarcomas, and uses thereof

Methods for treating muscular dystrophy

SYNGAP1 DYSFUNCTIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS FOR MENTAL RETARDATION

Compositions and Methods for Characterizing Breast Cancer

Traceability of cellular cycle anomalies targeting oncology and neurodegeneration

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

METHOD FOR THE IDENTIFICATION OF MEMORY MODULATING COMPOUNDS BY ASSESSING KIBRA EXPRESSION

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response

GENE EXPRESSION SIGNATURES ASSOCIATED WITH RESPONSE TO IMATINIB MESYLATE IN GASTROINTESTINAL STROMAL TUMORS AND USE THEREOF FOR PREDICTING PATIENT RESPONSE TO THERAPY AND IDENTIFICATION OF AGENTS WHICH HAVE EFFICACY FOR THE TREATMENT OF CANCER

GNA11 mutations in melanoma

GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

Methods of increasing bone mass in a subject comprising inhibiting DKK1

Compounds and uses thereof to induce an immunogenic cancer cell death in a subject

Selective reduction of allelic variants

YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF

Recurrent gene fusions in prostate cancer

BIOMARKERS BASED ON A MULTI-CANCER INVASION-ASSOCIATED MECHANISM

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

Gammaretrovirus Associated With Cancer

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3

KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK

Markers for Obesity and Methods of Use Thereof

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF

COMPOSITIONS AND METHODS FOR DETERMING CANCER SUSCEPTIBILITY

METHODS AND COMPOSITIONS FOR DIAGNOSING PULMONARY FIBROSIS SUBTYPES AND ASSESSING THE RISK OF PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION

COMPOSITIONS AND METHODS FOR DETECTING NOONAN SYNDROME

GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF

Treatment of cancer by inhibiting activity or expression of late SV-40 factor

Modulation of angiopoietin-like 3 expression

SUSCEPTIBILITY TO HSP90-INHIBITORS

METHODS OF DIAGNOSING ENDOMETRIOSIS

Map kinase kinase kinase kinase 3 (MAP4K3) as a biomarker and therapeutic target for autoimmune disease, cancer, inflammation and IL-17-associated disease

Treatment of neuroinflammatory conditions using antibodies directed against MCAM

Methods for the identification, assessment, and treatment of patients with cancer therapy

METHOD AND APPARATUS FOR CORRELATING LEVELS OF BIOMARKER PRODUCTS WITH DISEASE

METHODS FOR PROGNOSIS AND MONITORING CANCER THERAPY

Compositions and Methods for Identifying Autism Spectrum Disorders

Method of screening compounds for treating bladder cancer

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER

Method for evaluating the sensitizing potential of a test compound

Compositions and methods for enhancing odorant receptor activity

SCREENING DEVICE CONTAINING NANOG PROMOTER, SOX2 PROMOTER, LIN 28 PROMOTER, OCT4 PROMOTER AND LUCIFERASE GENE AND SCREENING METHOD THEREOF

Prevention and treatment of osteoarthritis

Methods and materials related to hair pigmentation and cancer

BRAF mutations conferring resistance to BRAF inhibitors

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

Methods for altering MRNA splicing and treating familial dysautonomia by administering kinetin, benzyladenine, and tocotrienols

MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma

CHEMO-SENSITIVITY ASSAYS USING TUMOR CELLS EXHIBITING PERSISTENT PHENOTYPIC CHARACTERISTICS

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

BCR-ABL1 SPLICE VARIANTS AND USES THEREOF

Methods and assays for the detection of alternative lengthening of telomeres (ALT) activity in cells

MOLECULAR MARKER FOR EVALUATING PATHOLOGICAL CONDITIONS AND TREATMENT OF MUSCULAR DYSTROPHY

Epidermal growth factor receptor mutations

PREDICTING BENEFIT OF ANTI-CANCER THERAPY VIA ARRAY COMPARATIVE GENOMIC HYBRIDIZATION

Lung Tumor Markers and Methods of Use Thereof

DIAGNOSIS AND MONITORING TREATMENT OF PSYCHIATRIC DISEASES WITH SPADIN AND RELATED METHODS

METHOD OF DIAGNOSIS

SENESCENCE MARKER, METHOD FOR EVALUATING SENESCENCE INHIBITOR, AND CANCER INHIBITOR

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

Tumor suppressor designated TS10Q23.3

Compositions and Methods for Treating and Diagnosing Cancer

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1

Diagnostic and Prognostic Markers for Cancer

PERINUCLEOLAR COMPARTMENT AS A CANCER MARKER

GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS

Brain Endothelial Cell Expression Patterns

Methods for identifying drug effects on a cell by determining changes in the cell's spliced message profile

Gene Expression Profiling for the Identification, Monitoring, and Treatment of Prostate Cancer

Recurrent gene fusions in prostate cancer

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

RBP4 in insulin sensitivity/resistance, diabetes, and obesity

Recurrent gene fusions in prostate cancer

Compositions and Methods for Diagnosis and Treatment of Breast Cancer

METHODS FOR DIAGNOSIS AND PROGNOSIS OF PULMONARY HYPERTENSION

METHOD FOR DETECTING ULCERATIVE COLITIS

Method of diagnosing and treating cancer using B-catenin splice variants

Gene defects and mutant ALK kinase in human solid tumors

Antibodies that bind polypeptides involved in the process of bone remodeling

MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CLL) and Uses Thereof

Ovarian Markers of Oocyte Competency and Uses Thereof

Quantification of IR-A and IR-B for tumor classification

Mutant Sodium Channel Nav1.7 and Methods Related Thereto

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS

BIOMARKERS PREDICTIVE OF PROGRESSION OF FIBROSIS

Methods for treating depression using NCAM peptide mimetics

POLYMORPHISMS ASSOCIATED WITH PARKINSON'S DISEASE

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF

GENETIC VARIANTS INDICATIVE OF VASCULAR CONDITIONS

Targets for use in diagnosis, prognosis and therapy of cancer

COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CERVICAL CANCER

Methods for diagnosis and treatment of endometrial cancer

SCREENING SYSTEM FOR MODULATORS OF HER2 MEDIATED TRANSCRIPTION AND HER2 MODULATORS IDENTIFED THEREBY

Construct for producing empty virus capsids

METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS

Treatment and prevention of dengue virus infections

Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Treatment of cancer and compositions

Therapeutic agent for tumor

Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA

TARGET GENES FOR CANCER THERAPY

Materials and methods useful for affecting tumor cell growth, migration and invasion

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF THYROID CANCER

TYPE 1 INTEFERON DIAGNOSTIC

ACE2 activation for treatment of heart, lung and kidney disease and hypertension

Renal Cell Carcinoma Biomarkers

BIOMARKER OF ALLERGIC DISEASE AND USE OF THE SAME

Method for screening active agents that stimulate the expression of CERT to improve the skin's barrier function

METHOD FOR SCREENING ACTIVE AGENTS THAT STIMULATE THE EXPRESSION OF ARNT2 TO IMPROVE THE SKIN'S BARRIER FUNCTION

Pestivirus species

Use of sarcoplasmic CA-ATPase type 2 protein for diagnosing and treating learning or mental disorders

Methods Of Administration And Treatment

PYRIDINE OR PYRIMIDINE DERIVATIVE HAVING EXCELLENT CELL GROWTH INHIBITION EFFECT AND EXCELLENT ANTI-TUMOR EFFECT ON CELL STRAIN HAVING AMPLIFICATION OF HGFR GENE

Method and Apparatus for Predicting Pharmacological Efficacy of Human Anti-TNFa Antibody Drug against Rheumatoid Arthritis

Viral and viral associated mirnas and uses thereof

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

NUTRIGENETIC BIOMARKERS FOR OBESITY AND TYPE 2 DIABETES

Islet1 (Isl1) and hearing loss

Cancer Specific Mitotic Network

HEART AGING BIOMARKERS AND METHODS OF USE

Genetic markers associated with risk of diabetes mellitus

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

BETA-DEFENSIN 2 GENETIC VARIATION PREDICTS H. PYLORI SUSCEPTIBILITY

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CARCINOMA

METHODS AND SYSTEMS FOR EVALUATING THE SENSITIVITY OR RESISTANCE OF TUMOR SPECIMENS TO CHEMOTHERAPEUTIC AGENTS

METHODS AND COMPOSITIONS RELATING TO FUSIONS OF ALK FOR DIAGNOSING AND TREATING CANCER

GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASE

Disease susceptibility

Diagnostic and treatment for chronic and acute phase myeloid leukemia

CANCER

METHODS RELATED TO A MUTATION IN COMPLEMENT FACTOR H-RELATED PROTEIN 5 IN PATIENTS WITH GLOMERULONEPHRITIS

Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer

NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 193P1E1B USEFUL IN TREATMENT AND DETECTION OF CANCER

GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA

Use of eIF3m for the diagnosis and treatment of cancer

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR METABOLIC SYNDROME

NOVEL ASSAY FOR DETECTING IMMUNE RESPONSES INVOLVING ANTIGEN SPECIFIC CYTOKINE AND/OR ANTIGEN SPECIFIC CYTOKINE SECRETING T-CELLS

METHOD OF REGENERATING ELASTIC FIBER AND SCREENING METHOD

BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS

METHODS FOR IDENTIFYING TARGETING DOMAINS AND METHOD AND COMPOSITIONS COMPRISING THE SAME

Method and means for treatment of osteoarthritis

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR OSTEOARTHRITIS

KIDNEY DISEASE TARGETS AND USES THEREOF

PNMT as a novel marker for progenitor cells

Diagnosis of depression

Gene expression profiles associated with chronic allograft nephropathy

Genetic variant of the annexin A5 gene

Spatial biomarker of disease and detection of spatial organization of cellular receptors

MATERIALS AND METHODS FOR THE IDENTIFICATION OF DRUG-RESISTANT CANCERS AND TREATMENT OF SAME